Lectin receptors mediating the clearance of cooled platelets. Short-term platelet cooling induces irreversible βGlcNAc exposure and clustering and recognition by macrophages bearing the α M β 2 integrin. Prolonged platelet refrigeration increases βgalactose exposure, hyper-aggregation of GPIbα molecules, and vWf binding to platelets. These changes induce clearance by asialoglycoprotein receptors on hepatocytes (Ashwell-Morell receptors) and macrophages (integrin α Μ β 2 ).
Asialoglycoprotein subunit 1 (N-18) and mouse antibody to human Asialoglycoprotein subunit 2 (G-17kk) were from Santa Cruz Biotechnology, Inc.; FITC-conjugated antibody to human GPIbα (SZ2) was from Immunotech.
Mouse platelet preparation. We obtained murine blood by retroorbital eye bleeding into 0.1 volume of Aster-Jandl anticoagulant from mice anesthetized with 3.75 mg ml -1 of Avertin. The anti-coagulated blood was centrifuged at 268 x g for 8 min at RT to obtain PRP. Platelets were separated from plasma proteins as described 2 . Platelets were suspended at a concentration of 5 x 10 9 ml -1 in platelet buffer or plasma for injection into recipient mice.
Human and mouse platelets were labeled with 1.8 µM CellTracker TM Orange CMTMR, or 2.5 µM CellTracker Green CMFDA 47 for 20 min at 37 °C 48 before storage for 0 to 48 h at 4 ºC. Unincorporated dye was removed by centrifugation 2 . Platelets were resuspended to 3 x 10 9 ml -1 in platelet poor plasma (PPP) before storage at 4 °C for 48 h.
Mouse platelets were biotinylated by incubation with 1 µg ml -1 Biotin-NHS for 1 h at RT.
Unbound biotin was removed by centrifugation 2 .
Mouse platelet recovery, survival and fate. We injected 1x10 8 CMFDA-labeled mouse platelets, 0 °C, 4 'C or 22 °C maintained into retroorbital venous plexus of syngeneic recipient mice. For recovery and survival determinations, blood samples were collected immediately (2 min), and at 5 min, 10 min, 0.5 h, 2 h, 24 h, 48 h, and 72 h. Whole blood analysis using flow cytometry (Becton Dickinson Biosciences) was performed and the percentage of CMFDA positive platelets determined 47 . 50,000 events were collected from each sample. In experiments using asialofetuin/fetuin and platelet co-transfusions the 2 min values of transfused platelets were set at 100%. In all other experiments, the values of transfused platelets measured at 5 min were set at 100 %. The survivals and recoveries were calculated as described 2, 47 . For biotinylated platelets the recoveries were 78.0 % ± 12 and 60.2 ± 9.25 (mean ± s.e.m.) for RT and long-term cooled platelets, respectively; the survivals were 72.34 ± 5.4 and 59.48 ± 3.9 for 22 °C and long-term refrigerated platelets, respectively. All other calculated platelet recoveries and survivals are summarized in table 1.
To evaluate the fate of platelets, tissues were harvested from recipient mice 1 h after the injection of 0.4 x 10 9 111 Indium-labeled (NEN Life Science Products) platelets. Platelets were radiolabeled after storage as decribed before 2 . Organ-weight was measured and radioactivity was determined from γ-count. Results are expressed as % of radioactivity per g organ relative to the total radioactivity injected. For recovery and survival determinations of radioactive platelets, blood samples were collected immediately (< 2 min), and at 0.5 h, 1 h and 24 h after platelet infusion and γ-count determined 49 .
For recovery and survival determinations of biotinylated platelets, blood samples were collected after 5 min, 2 h, 24 h, 48 h and 72 h by intraorbital bleeding. PRP was separated from whole blood by centrifugation, and biotinylated platelets were detected after labeling with Streptoavidin-PE (1:1000). The percentage of biotinylated platelets was determined by flow cytometry. 50,000 events were collected in each sample.
Enzymatic galactosylation of human and mouse platelets. Mouse CMFDA-labeled platelets (10 9 ml -1 ) were suspended in mouse plasma incubated with 1.2 mM uridine 5'-diphosphogalactose (UDP-Gal) for 60 min at 37 °C in platelet rich plasma prior to storage at 4 °C 10 .
Platelet clearance inhibition studies using asialofetuin and fetuin. A bolus of 10 mg asialofetuin or fetuin was injected via the retroorbital venous plexus into WT C57/Bl6 mice 2 min before the platelet transfusion. Following platelet transfusion, 5 mg asialofetuin or fetuin was injected i.v. at time points of 10, 20, 30 and 60 min. The recipient animals were bled at 2, 10, 30, 90 min and the survival of labeled platelets determined by flow cytometry, as described above.
In vitro HepG2 based platelet ingestion assay. We maintained human HepG2 hepatocarcinoma cells in αMEM (GIBCO Invotrigen), 2% heat-inactivated bovine calf serum (BCS), 3% standard fetal bovine serum (FBS), and 1% of a penicillin and streptomycin solution composed of 10,000 U ml -1 penicillin G and 10 mg ml Removal of the extracellular domain of GPIbα. GPIbα was enzymatically cleaved from the surface of human or mouse platelets in platelet buffer containing 1 mM Ca 2+ and 10 µg ml -1 of the snake venom metalloprotease mocarhagin 38 or 10 µg ml -1 Osialoglycoprotein endopeptidase, respectively. After the enzymatic digestion, the platelets were washed by centrifugation, resuspended in platelet poor plasma (PPP), and allowed to rest for 30 min at 37 °C before storage at 4 °C. The extent of GPIbα removal was monitored by flow cytometry using 5 µg ml -1 of the FITC-conjugated antibody to human GPIbα (clone SZ2) or 5 µg ml -1 of the PE-conjugated antibody to mouse GPIbα (clone Xia.G5). Surface labeling of platelet GPIbα. Mouse platelets, maintained at RT or chilled, were applied to glass coverslips by centrifugation at 280 x g in PBS containing 0.05% glutaraldehyde, fixed with 0.5% glutaraldehyde in PBS for 10 min, quenched with 0.1% sodium borohydride in PBS and washed extensively with PBS containing 1% BSA.
GPIbα was labeled with a mixture of three rat anti-mouse GPIbα monoclonal antibodies, each at 10 µg ml -1 for 1 h, followed by incubation with 10 nm gold conjugated goat antirat IgG for 3 h. The coverslips were washed, fixed with 1% glutaraldehyde and prepared for electron microscopy as described 50 .
Gold particles were quantified on the replica surface of RT or chilled platelets. Images were scanned at 1600 dpi resolution and 8-bit depth using Adobe Photoshop 7.0. Files were saved as TIFF format. An area of 800 x 800 pixels was selected and pasted into a new file. The background was removed from the image by using the Brightness/Contrast tool to prevent false positives. Gold size calibration was done in Image J (J 1.32j).
Threshold range was 0-170. Center of mass and area was recorded to 8 decimal places.
Particles at a size between 20 and 150 nm 2 were used for nearest neighbor analysis. All particles at a size of >20 nm 2 were used for area analysis. The areas of more than 100 single gold particles were measured as a size control.
Immunoblot analysis and immunoprecipitation. Prior to lysis, platelets were washed 1x by centrifugation as described above and resuspended in platelet buffer at 4 x 10 8 platelets ml -1 . For immunoblotting, platelets were lysed with 1/3 volume of 3x lysis buffer (3% Nonidet P-40, 150 mM Tris/HCl, pH 7.4, 450 mM NaCl, 3 mM EGTA, 3 mM PMSF, 3 mM Na 3 VO 4 , 30 µg ml -1 leupeptin and 30 µg ml -1 aprotinin) 52 and by the addition of 1/4 volume of 4X SDS-PAGE loading buffer containing 5% β-mercaptoethanol 53 .
For immunoprecipitation experiments, platelets were lysed by the addition of 0.5 volume of 3x lysis buffer (3% Nonidet P-40, 150 mM Tris/HCl, pH 7.4, 450 mM NaCl, 3 mM EGTA, 3 mM PMSF, 3 mM Na 3 VO 4 , 30 µg ml -1 leupeptin and 30 µg ml -1 aprotinin) 52 .
Insoluble material was removed by centrifugation at 14,000 x g for 10 min and the soluble fraction was immunoprecipitated with 2 µg of the antibody to mouse GPIbα (clone Xia G7) and antibodies bound to protein G-Sepharose beads (Pharmacia). Immune complexes were collected and solubilized in SDS-PAGE buffer containing 5% β-mercaptoethanol.
Proteins were displayed by SDS-PAGE on 7.5% precast polyacrylamide gels (Lonza) and transferred onto Immobilon-P membrane (Millipore). Membranes were blocked using 1%
BSA in 100 mM NaCl, 20 mM Tris/HCl, pH 7.4 and probed with a mixture of 1 µg ml -1 of the antibodies to mouse GPIbα (XiaG7, Xia B2 and Xia G5) followed by the appropriate peroxidase-tagged secondary antibodies, or with 1 µg ml -1 of peroxidase conjugated-sWGA or 0.4 µgml -1 RCA I, or 1 µg ml -1 of rabbit anti human vWf antibody followed by peroxidase-tagged secondary antibodies. Detection was performed with an enhanced chemiluminescence system (Pierce).
